{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:40:41Z","timestamp":1791175241344,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polycystic kidney disease (PCKD) is the most common hereditary cause of end-stage renal disease, the complications of which may prevent the choice of peritoneal dialysis (PD). The aim of this study was to explore the effects of dialysis modality on outcomes in patients with PCKD. We extracted a cohort of 1417 adult patients with PCKD initiating long-term dialysis therapy in 1999\u20132010 from the Taiwan National Health Insurance Research Database, among which 125 patients chose PD. The patients on HD were older and had a higher comorbidity index compared to those on PD. We compared the risks for death, hospitalization and medical expenditures between the patients on PD and propensity-score matched patients on hemodialysis (HD). The overall survival did not differ between the patients on PD and HD. The patients on PD tended to have higher hazard ratios (HR) for the first episode of hospitalization (adjusted HR 1.34 [95% CI, 1.04\u22121.79]). The annual medical expenses were 10% lower for the patients on PD. PD is an equivalent choice of renal replacement therapy to HD for patients with PCKD in terms of survival. Although the patients on PD had a higher risk for hospitalization, the medical expenditure for PD was 10% lower.<\/jats:p>","DOI":"10.1038\/srep12816","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T09:31:02Z","timestamp":1438853462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis"],"prefix":"10.1038","volume":"5","author":[{"given":"Ju-Yeh","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likwang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ter","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Wah","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Liong","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon-Yen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenq-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"BFsrep12816_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMra022161","volume":"350","author":"PD Wilson","year":"2004","unstructured":"Wilson, P. D. Polycystic kidney disease. The New England journal of medicine 350, 151\u2013164 (2004).","journal-title":"The New England journal of medicine"},{"key":"BFsrep12816_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow, P. A. et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney international 41, 1311\u20131319 (1992).","journal-title":"Kidney international"},{"key":"BFsrep12816_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone, R. D., Ruthazer, R. & Terrin, N. C. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. American journal of kidney diseases : the official journal of the National Kidney Foundation 38, 777\u2013784 (2001).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR4","doi-asserted-by":"publisher","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","volume":"29 Suppl 4","author":"EM Spithoven","year":"2014","unstructured":"Spithoven, E. M. et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 29 Suppl 4, iv15\u2013iv25 (2014).","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"BFsrep12816_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1053\/j.ajkd.2013.09.011","volume":"63","author":"C van Walraven","year":"2014","unstructured":"van Walraven, C., Manuel, D. G. & Knoll, G. Survival trends in ESRD patients compared with the general population in the United States. American journal of kidney diseases : the official journal of the National Kidney Foundation 63, 491\u2013499 (2014).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR6","doi-asserted-by":"publisher","first-page":"c42","DOI":"10.1159\/000334429","volume":"120","author":"R Haynes","year":"2012","unstructured":"Haynes, R., Kheradmand, F. & Winearls, C. G. Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study. Nephron. Clinical practice 120, c42\u2013c47 (2012).","journal-title":"Nephron. Clinical practice"},{"key":"BFsrep12816_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00508-005-0492-y","volume":"117 Suppl 6","author":"FC Prischl","year":"2005","unstructured":"Prischl, F. C. et al.Peritoneal dialysis in patients with polycystic kidney disease. Wiener klinische Wochenschrift 117 Suppl 6, 24\u201328 (2005).","journal-title":"Wiener klinische Wochenschrift"},{"key":"BFsrep12816_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.ajkd.2011.01.019","volume":"57","author":"L Li","year":"2011","unstructured":"Li, L. et al. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation 57, 903\u2013907 (2011).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/ki.2008.352","volume":"74","author":"S Kumar","year":"2008","unstructured":"Kumar, S., Fan, S. L., Raftery, M. J. & Yaqoob, M. M. Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis. Kidney international 74, 946\u2013951 (2008).","journal-title":"Kidney international"},{"key":"BFsrep12816_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5414\/CNP57208","volume":"57","author":"KC Abbott","year":"2002","unstructured":"Abbott, K. C. & Agodoa, L. Y. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clinical nephrology 57, 208\u2013214 (2002).","journal-title":"Clinical nephrology"},{"key":"BFsrep12816_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1053\/j.ajkd.2014.05.020","volume":"64","author":"S Reule","year":"2014","unstructured":"Reule, S. et al. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. American journal of kidney diseases : the official journal of the National Kidney Foundation 64, 592\u2013599 (2014).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.5301\/jn.5000224","volume":"26","author":"PW Lee","year":"2013","unstructured":"Lee, P. W., Chien, C. C., Yang, W. C., Wang, J. J. & Lin, C. C. Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: a national study in Taiwan. Journal of nephrology 26, 755\u2013762 (2013).","journal-title":"Journal of nephrology"},{"key":"BFsrep12816_CR13","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2013.11.001","volume":"63","author":"AJ Collins","year":"2014","unstructured":"Collins, A. J. et al. US Renal Data System 2013 Annual Data Report. American journal of kidney diseases : the official journal of the National Kidney Foundation 63, A7 (2014).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR14","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1046\/j.1523-1755.2000.00115.x","volume":"57","author":"SW Murphy","year":"2000","unstructured":"Murphy, S. W. et al. Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney international 57, 2557\u20132563 (2000).","journal-title":"Kidney international"},{"key":"BFsrep12816_CR15","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2215\/CJN.00440112","volume":"7","author":"JP Lafrance","year":"2012","unstructured":"Lafrance, J. P. et al. Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis. Clinical journal of the American Society of Nephrology : CJASN 7, 1598\u20131605 (2012).","journal-title":"Clinical journal of the American Society of Nephrology : CJASN"},{"key":"BFsrep12816_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2008.06.013","volume":"52","author":"VA Kumar","year":"2008","unstructured":"Kumar, V. A., Ledezma, M. L., Idroos, M. L., Burchette, R. J. & Rasgon, S. A. Hospitalization rates in daily home hemodialysis versus peritoneal dialysis patients in the United States. American journal of kidney diseases : the official journal of the National Kidney Foundation 52, 737\u2013744 (2008).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1523-1755.2005.00413.x","volume":"68","author":"YC Shih","year":"2005","unstructured":"Shih, Y. C., Guo, A., Just, P. M. & Mujais, S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney international 68, 319\u2013329 (2005).","journal-title":"Kidney international"},{"key":"BFsrep12816_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1053\/ajkd.2002.34924","volume":"40","author":"H Lee","year":"2002","unstructured":"Lee, H. et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. American journal of kidney diseases : the official journal of the National Kidney Foundation 40, 611\u2013622 (2002).","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"BFsrep12816_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3747\/pdi.2012.00081","volume":"33","author":"TW Kao","year":"2013","unstructured":"Kao, T. W. et al. Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 33, 671\u2013678 (2013).","journal-title":"Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis"},{"key":"BFsrep12816_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11192-010-0289-2","volume":"86","author":"H-Y Yeh","year":"2011","unstructured":"Yeh, H.-Y., Wu, J.-C., Haschler, I., Chen, T.-J. & Wetter, T. Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics. Scientometrics 86, 365\u2013380 (2011).","journal-title":"Scientometrics"},{"key":"BFsrep12816_CR21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jclinepi.2014.05.012","volume":"67","author":"VC Wu","year":"2014","unstructured":"Wu, V. C. et al. Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan. Journal of clinical epidemiology 67, 1139\u20131149 (2014).","journal-title":"Journal of clinical epidemiology"},{"key":"BFsrep12816_CR22","first-page":"157","volume":"104","author":"CC Lin","year":"2005","unstructured":"Lin, C. C., Lai, M. S., Syu, C. Y., Chang, S. C. & Tseng, F. Y. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi 104, 157\u2013163 (2005).","journal-title":"Journal of the Formosan Medical Association = Taiwan yi zhi"},{"key":"BFsrep12816_CR23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng, C. L., Kao, Y. H., Lin, S. J., Lee, C. H. & Lai, M. L. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiology and drug safety 20, 236\u2013242 (2011).","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"BFsrep12816_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1681\/ASN.2013060610","volume":"25","author":"VC Wu","year":"2014","unstructured":"Wu, V. C. et al. Long-term risk of coronary events after AKI. Journal of the American Society of Nephrology : JASN 25, 595\u2013605 (2014).","journal-title":"Journal of the American Society of Nephrology : JASN"},{"key":"BFsrep12816_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical care 43, 1130\u20131139 (2005).","journal-title":"Medical care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep12816","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12816.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep12816.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:50:04Z","timestamp":1672955404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep12816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,10,16]]}},"alternative-id":["BFsrep12816"],"URL":"https:\/\/doi.org\/10.1038\/srep12816","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]},"assertion":[{"value":"23 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12816"}}